Randomized Prospective Phase III Trial of Difluoromethylornithine vs Placebo in Preventing Recurrence of Completely Resected Low Risk Superficial Bladder Cancer - Concepedia

Concepedia

Publication | Closed Access

Randomized Prospective Phase III Trial of Difluoromethylornithine vs Placebo in Preventing Recurrence of Completely Resected Low Risk Superficial Bladder Cancer

45

Citations

21

References

2006

Year

Edward M. Messing, Kyung Mann Kim, Francis E. Sharkey, M. Schultz, Howard L. Parnes, Daniel J. Kim, Daniel R. Saltzstein, George Wilding

The Journal of Urology

Abstract

A year of difluoromethylornithine did not prevent recurrence of completely resected low risk superficial bladder cancer, when started shortly after surgery.

References

	Year	Citations

Page 1